The AHA, joined by several other national groups representing 340B hospitals, Feb. 19 urged the Health Resources and Services Administration to extend the timeline for stakeholders to submit comments to the agency’s recent request for information on a new 340B rebate model program.

Specifically, the groups urged HRSA to extend the comment deadline to April 20 to give stakeholders sufficient time to gather information and provide complete answers to dozens of detailed questions contained in the RFI. The current deadline for comments is March 19.

“In general, this timeline would better allow stakeholders, including the 340B hospital field, to provide the agency with meaningful feedback,” the groups wrote. “As HRSA has previously recognized, a rebate mechanism would upend more than 30 years of practice using an upfront discount mechanism. This modest extension is necessary to fulfill the agency’s own stated goal of ensuring ‘a fair and transparent comment process for all stakeholders.’ Indeed, without an extension, we have serious concerns whether the agency will be able to consider all aspects of the problem.”

In addition to the AHA, today’s letter was signed by America’s Essential Hospitals, American Society of Health-Systems Pharmacists, Association of American Medical Colleges, Catholic Health Association of the United States, Children’s Hospital Association, and 340B Health. 

Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…
Headline
The U.S. District Court for the District of Columbia March 31 vacated a Health Resources and Services Administration policy instituted in 2013 that restricted…
Headline
The U.S. Court of Appeals for the 4th Circuit March 31 upheld a preliminary injunction issued by the U.S. District Court for the District of West Virginia…
Headline
 The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect…
Headline
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on its request for information on…
Headline
The U.S. District Court for the District of Hawaii Feb. 23 denied a preliminary injunction requested by AstraZeneca in a case challenging the state’s law…